Projektinformation
Beskrivning
The DIRECT Consortium aims to discover and validate biomarkers that: (1) predict the rate of glycaemic deterioration before and after type 2 diabetes onset; (2) predict the response to diabetes therapies; and (3) help stratify type 2 diabetes into
clearly definable disease subclasses that can be treated more effectively.
clearly definable disease subclasses that can be treated more effectively.
| Kort titel | DIRECT |
|---|---|
| Akronym | IMI DIRECT |
| Status | Slutfört |
| Gällande start-/slutdatum | 2012/05/16 → 2019/07/31 |
Samarbetspartner
- Lunds universitet (huvudsaklig)
Ämnesklassifikation (UKÄ)
- Medicin och hälsovetenskap